Sarah O'Brien - Sep 15, 2022 Form 4 Insider Report for Provention Bio, Inc. (PRVB)

Role: Chief People Officer
Signature: /s/ Thierry Chauche, as attorney-in-fact
Stock symbol: PRVB
Transactions as of: Sep 15, 2022
Transactions value $: $0
Form type: 4
Date filed: 9/19/2022, 04:07 PM
Next filing: Jan 11, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRVB	Stock Option (right to buy)	Award	$0	+100K		$0.00	100K	Sep 15, 2022	Common Stock, par value $0.0001	100K	$5.35	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On September 15, 2022, the Reporting Person was granted a stock option for 100,000 shares of Common Stock which vests in four equal annual installments commencing on September 15, 2022. Reporting Person was also granted 100,000 stock options under the Issuer's 2020 Inducement Plan, as amended, with performance-based vesting triggers that will be reported, if and when vested, consistent with the applicable reporting requirements.
F2	The stock options were granted pursuant to the Issuer's 2020 Inducement Plan, as amended.

Content

On September 15, 2022, the Reporting Person was granted a stock option for 100,000 shares of Common Stock which vests in four equal annual installments commencing on September 15, 2022. Reporting Person was also granted 100,000 stock options under the Issuer's 2020 Inducement Plan, as amended, with performance-based vesting triggers that will be reported, if and when vested, consistent with the applicable reporting requirements.

The stock options were granted pursuant to the Issuer's 2020 Inducement Plan, as amended.